CoRegen Wins FDA IND Clearance for CRG-150
HOUSTON, July 7, 2026 CoRegen, Inc. has received U.S. Food and Drug Administration (FDA) Investigational New Drug (IND) clearance...
solid tumors
Advertisement
GSK Completes Nuvalent Acquisition to Expand Lung Cancer
LONDON, July 16, 2026 GSK plc has officially completed its acquisition of Nuvalent, Inc., marking a major strategic expansion...
Moderna Doses First Patient in mRNA-4200 Cancer Trial
CAMBRIDGE, Mass., July 16, 2026 Moderna, Inc. has announced the first participant has been dosed in its Phase 1...
Zelluna Doses First Patient With TCR-NK Therapy
OSLO, Norway, July 13, 2026 Zelluna announced that the first patient has been dosed in the ZIMA-101 Phase 1...
LTZ Therapeutics Receives FDA IND Clearance for LTZ-232
REDWOOD CITY, Calif., July 7, 2026 LTZ Therapeutics announced that the U.S. Food and Drug Administration (FDA) has cleared...
Advertisements
Anixa Biosciences Advances Ovarian Cancer CAR-T to Highest Dose
SAN JOSE, California, July 6, 2026 Anixa Biosciences, Inc. and Moffitt Cancer Center have announced a significant milestone in...
Calidi Showcases RedTail Platform at T-Cell Engager Therapeutic Summit
SAN DIEGO, June 24, 2026 Calidi Biotherapeutics presented new preclinical data on CLD-501, its investigational in situ T-cell engager...
Quest Diagnostics Secures New York Approval for Haystack MRD Cancer Test
SECAUCUS, N.J., June 24, 2026 Quest Diagnostics announced that the New York State Department of Health’s Clinical Laboratory Evaluation...
Antengene Signs Up to $1.9 Billion TCE Licensing Deal
BOSTON, Singapore and Hong Kong, June 22, 2026 Antengene Corporation Limited has announced a landmark strategic licensing agreement with...
Jazz and AbCellera Partner on Next-Gen Cancer Antibodies
DUBLIN, Ireland and VANCOUVER, British Columbia, June 17, 2026 Jazz Pharmaceuticals and AbCellera have announced a major strategic collaboration...
Advertisement
